Gary Nachman
Stock Analyst at Raymond James
Total Price Targets
11
Stocks Covered
6
Sectors
Healthcare
Most Recent
Nov 3, 2025
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Gary Nachman
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | $256.00 | $206.29 | +24.1% | 6 | Nov 3, 2025 |
| IONS | Ionis Pharmaceuticals, Inc. | $75.00 | $75.86 | -1.1% | 1 | Sep 22, 2025 |
| SDGR | Schrödinger, Inc. | $28.00 | $12.37 | +126.4% | 1 | Nov 13, 2024 |
| ABCL | AbCellera Biologics Inc. | $5.00 | $4.46 | +12.1% | 1 | Nov 5, 2024 |
| ANIP | ANI Pharmaceuticals, Inc. | $83.00 | $80.00 | +3.8% | 1 | Sep 18, 2024 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $175.00 | $297.62 | -41.2% | 1 | Feb 11, 2022 |
Recent Activity
- Nov 3, 2025— Set$256.00price target onABBV(AbbVie Inc.)
- Oct 17, 2025— Set$250.00price target onABBV(AbbVie Inc.)
- Sep 22, 2025— Set$75.00price target onIONS(Ionis Pharmaceuticals, Inc.)
- Feb 3, 2025— Set$220.00price target onABBV(AbbVie Inc.)
- Nov 13, 2024— Set$28.00price target onSDGR(Schrödinger, Inc.)
- Nov 5, 2024— Set$5.00price target onABCL(AbCellera Biologics Inc.)
- Sep 18, 2024— Set$83.00price target onANIP(ANI Pharmaceuticals, Inc.)
- Sep 29, 2023— Set$177.00price target onABBV(AbbVie Inc.)
- Apr 26, 2022— Set$174.00price target onABBV(AbbVie Inc.)
- Feb 11, 2022— Set$175.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- Jan 18, 2022— Set$153.00price target onABBV(AbbVie Inc.)
Frequently Asked Questions
Who is Gary Nachman?
Gary Nachman is a stock analyst at Raymond James covering 6 stocks primarily in Healthcare. They have issued 11 price targets since Jan 18, 2022.
What stocks does Gary Nachman cover?
Gary Nachman currently covers 6 stocks, including ABBV, IONS, SDGR, ABCL, ANIP.
What is Gary Nachman's latest price target?
Gary Nachman's most recent price target was $256.00 on ABBV (AbbVie Inc.), set on Nov 3, 2025.
What is Gary Nachman's highest price target?
Gary Nachman's highest issued price target is $256.00 on ABBV, set on Nov 3, 2025.
More Analysts at Raymond James
Coverage based on publicly published price targets. Not investment advice.